APGEApogee Therapeutics, Inc.

$134.93

$134.93

$34.6552 weeks$134.93

The financials

Apogee Therapeutics, Inc. by the numbers

Apogee Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statement	Q2 2026	Q2 2025	Change
Operating income	−$96M	−$73M	n/a
Net income	−$86M	−$66M	n/a
Diluted EPS	−$1.14	−$1.13	n/a

Biotechnology

Ranks #3 of 145 by Smart Score

Kymera Therapeutics, Inc.

Krystal Biotech, Inc.

Praxis Precision Medicines, Inc.

Corcept Therapeutics Incorporated

Cytokinetics, Incorporated